PCDHGB7 and hypoparathyroidism-retardation-dysmorphism syndrome: PCDHGB7 demonstrated a positive correlation with inhibitory immune cells and a negative correlation with tumor mutational burden (TMB) and homologous recombination deficiency (HRD).